These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7178143)

  • 1. Technical and emotional aspects of plasmapheresis.
    Becker D
    Prog Clin Biol Res; 1982; 106():403-19. PubMed ID: 7178143
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasmapheresis on blood fractionators].
    Kalinin NN; Petrova VI; Movshev BE; Petrov MM; Dubrovina NA
    Sov Med; 1988; (12):23-6. PubMed ID: 3149425
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced blood-to-tissue albumin movement after plasmapheresis.
    Stahl AM; Gillen CM; Takamata A; Nadel ER; Mack GW
    Shock; 2003 May; 19(5):440-7. PubMed ID: 12744487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The monitoring of protein-volemic indices during plasmapheresis in patients with paraproteinemic hemoblastoses].
    Kalinin NN; Movshev BE; Petrov MM; Petrova VI; Droshneva VA; Varlamova SV; Khoroshko ND; Zhuravlev VS; Loginov SP
    Ter Arkh; 1996; 68(7):62-5. PubMed ID: 8928075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis therapy of pemphigus.
    Bystryn JC
    Arch Dermatol; 1988 Nov; 124(11):1702-4. PubMed ID: 3178250
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of the percent of exchanged plasma in continuous membrane separation and substitution with human albumin].
    Muschmov D; Kirjakov Z; Stantschev I
    Z Urol Nephrol; 1986 Jun; 79(6):325-7. PubMed ID: 3751354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
    Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
    Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allergic reactions to corticosteroid ointments, locarcorten and lorinden].
    Soloshenko EN
    Vestn Dermatol Venerol; 1977 May; (5):56-8. PubMed ID: 878585
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluid therapy in shock.
    Moss GS; Lowe RJ; Jilek J; Levine HD
    Prog Clin Biol Res; 1982; 108():51-63. PubMed ID: 7178149
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders.
    Lehmann HC; Hartung HP; Hetzel GR; Stüve O; Kieseier BC
    Arch Neurol; 2006 Aug; 63(8):1066-71. PubMed ID: 16908731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP)].
    Baba M; Ogawa M; Matsunaga M
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1336-7. PubMed ID: 9128399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burn wheel: a guide to burn resuscitation.
    Smith CE; Milner SM
    Emerg Med Serv; 2001 Mar; 30(3):76-7, 90. PubMed ID: 11258307
    [No Abstract]   [Full Text] [Related]  

  • 13. [Postcorticotherapy syndrome].
    Mozziconacci P; Combourieu M
    Therapeutique; 1969 May; 45(5):534-5. PubMed ID: 5797692
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of long-term plasmapheresis on blood composition. I. Changes in the concentration of total proteins, electrophoretic fractions and immunoglobulins].
    Grgicević D; Pende B
    Bilt Hematol Transfuz; 1981; 9(1-3):77-88. PubMed ID: 7349761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmapheresis in the treatment of trichinellosis.
    Lapiński TW; Prokopowicz D; Miegoć H
    Wiad Parazytol; 1997; 43(3):265-70. PubMed ID: 9557595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of selective albumin collection system by double filtration plasmapheresis.
    Mineshima M; Agishi T; Kaneko I; Era K; Ota K; Ide K; Fukui K
    Prog Clin Biol Res; 1990; 337():499-501. PubMed ID: 2353011
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasmapheresis with a substitution solution of human serum protein (5%) versus plasmapheresis with a substitution solution of human albumin (5%) in patients suffering from autoimmune diseases.
    Bambauer R; Arnold A
    Artif Organs; 1999 Dec; 23(12):1079-87. PubMed ID: 10619926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of the Guillain-Barré syndrome in childhood by plasmapheresis].
    Hernández González A; Rubio Quiñones F; Quintero Otero S; Cozar Navarro L; Cañibano MA; Capote Huelva FJ; Alvarez C; Pantoja Rosso S
    An Esp Pediatr; 1993 Sep; 39(3):240-2. PubMed ID: 8250439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasmapheresis as a method of production of blood fractions].
    Lautner A
    Bibl Haematol; 1969; 32():212-6. PubMed ID: 5822799
    [No Abstract]   [Full Text] [Related]  

  • 20. Tandem plasmapheresis and haemodialysis as a safe procedure in 82 patients with immune-mediated disease.
    Dechmann-Sültemeyer T; Linkeschova R; Lenzen K; Kuril Z; Grabensee B; Voiculescu A
    Nephrol Dial Transplant; 2009 Jan; 24(1):252-7. PubMed ID: 18682492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.